Skip to main content

Posts

Showing posts with the label event

E3 2020 loses creative managers IAM8bit, Devolver changes his press conference plans

The E3 2020 lost the IAM8BIT creative managers, who have recently been announced as responsible for creating a new showfloor experience for participants. IAM8BIT revealed the news on Twitter without adding a lot of information to this, saying that it was a dream of being involved in the organization of the event but that it decided to resign for reasons not specified. It is with mixed emotions that Iam8bit decided to resign as creative directors of what was going to be an E3 2020 scalable floor experience, reads the tweet. We have produced hundreds of games of games + community and it was a dream of being involved with E3. We wish good luck to the organizers. The partnership had only been announced in January, the event should start on June 9 in Los Angeles. The organization of the E3 2020 is not in great form after Sony has announced that it would not know the event for the second year in a row, and the producer and animator of Game Awards, Geoff Keighley, revealed that he Do n...

ESO: We show you how you are great

A SARS COV 2 vaccine, also referred to as Covid-19 vaccine (English Covid-19 Vaccine) and colloquially as Corona vaccine, is a vaccine (vaccine) against the Coronavirus SARS COV-2 occurring since the beginning of 2020, The Covid-19 pandemic triggered. The aim of vaccine development is to produce an adaptive immune response in the vaccinated organism by vaccination, which protects COVID-19 prior to infection with the virus and thus before the disease. Like all medicines, COVID-19 vaccines are also subjected to a clinical trial before applying for a clinical trial before the drug approval - by way of circulation - can be requested across the competent authority. Although this process in the Corona vaccines took place faster than usual, no test step was disabled, shortened or simplified in Europe. The reason for speed was instead, especially in new and improved technology, already existing prior knowledge through SARS-COV-1, considerable financial support and the parallel implementation o...